Want to see FR:ALAFY full AI Analyst Report?

AFYREN (ALAFY) Price & Analysis

1 Followers

ALAFY Stock Chart & Stats

€2.74

>-€0.01(-0.18%)

At close: Jul 27 4:00 PM EDT

€2.74

>-€0.01(-0.18%)

Day’s Range― - ―

52-Week Range€2.07 - €3.24

Previous CloseN/A

Volume4.04K

Average Volume (3M)11.99K

Market Cap

€99.46M

Enterprise Value€122.72

Total Cash (Recent Filing)€17.30M

Total Debt (Recent Filing)€8.85M

Price to Earnings (P/E)―

Beta-0.06

Next Earnings

Mar 24, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.20

Shares Outstanding38,852,520

10 Day Avg. Volume10,461

30 Day Avg. Volume11,993

Financial Highlights & Ratios

PEG Ratio-0.12

Price to Book (P/B)1.22

Price to Sales (P/S)33.31

P/FCF Ratio-14.32

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.64

Revenue Forecast (FY)€4.15M

Bulls Say, Bears Say

Bulls Say

Low Financial LeverageMeaningfully reduced debt and low leverage provide AFYREN with greater financial flexibility than its earnings profile alone would suggest. This balance-sheet capacity can help the company fund operations, manage volatility, and pursue industrial ramp-up without relying entirely on additional borrowing.

Proprietary Bio-based Chemistry PlatformAFYREN’s fermentation platform targets replacement of petroleum-derived chemicals with bio-based alternatives, giving the business a structural sustainability proposition. If industrial execution improves, this technology can support differentiated products and longer-term customer adoption across chemicals markets.

Diversified End-market ApplicationsExposure to several end markets broadens the potential customer base and reduces reliance on a single application. The acids’ use across food, feed, materials, and specialty chemicals creates multiple routes for commercial development as customers seek bio-based substitutes for fossil-derived inputs.

Bears Say

Sustained Revenue DeclineRepeated revenue contraction indicates that AFYREN has not yet translated its technology and market opportunity into sustained commercial growth. Continued top-line pressure can weaken operating leverage, reduce production utilization, and make it harder for the business to absorb fixed industrial costs.

Deepening UnprofitabilityThe move from positive gross profit in 2021–2023 to a large gross loss in 2025 shows that current pricing, scale, or cost economics are not supporting a sustainable earnings model. Wider net losses increase pressure on future capital needs and delay the path to self-funded growth.

Persistent Cash BurnPersistent negative operating and free cash flow means AFYREN is not yet funding its business internally. Even with modest improvement in 2025, ongoing cash consumption can limit investment flexibility, increase dependence on financing, and leave less capacity to withstand delays in industrial ramp-up or customer volumes.

AFYREN News

AFYREN and Terrial Renew Multi‑Year Potassium Fertilizer Alliance

AFYREN ( ($FR:ALAFY) ) just unveiled an announcement. AFYREN and Terrial have renewed their strategic partnership with a...

21h ago

AFYREN Takes Full Control of Flagship Plant as Production and Pre-Sold Volumes Surge

AFYREN ( ($FR:ALAFY) ) has provided an update. AFYREN has strengthened its industrial profile by acquiring the remaining...

5d ago

AFYREN scales bio-based acid output and strengthens climate-resilient positioning

AFYREN ( ($FR:ALAFY) ) has shared an announcement. AFYREN has crossed the milestone of 1,000 tonnes of bio-based...

1M ago

AFYREN Details Share Capital and Voting Rights Structure as of July 31, 2026

AFYREN ( ($FR:ALAFY) ) has provided an update. AFYREN, a French greentech company listed on Euronext Growth Paris,...

2M ago

ALAFY FAQ

What was AFYREN’s price range in the past 12 months?

AFYREN lowest stock price was €2.06 and its highest was €3.23 in the past 12 months.

What is AFYREN’s market cap?

AFYREN’s market cap is €99.46M.

When is AFYREN’s upcoming earnings report date?

AFYREN’s upcoming earnings report date is Mar 24, 2027 which is in 175 days.

How were AFYREN’s earnings last quarter?

AFYREN released its earnings results on Sep 25, 2026. The company reported €0.06 earnings per share for the quarter.

Is AFYREN overvalued?

According to Wall Street analysts AFYREN’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does AFYREN pay dividends?

AFYREN does not currently pay dividends.

What is AFYREN’s EPS estimate?

AFYREN’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does AFYREN have?

AFYREN has 38,852,520 shares outstanding.

What happened to AFYREN’s price movement after its last earnings report?

AFYREN reported an EPS of €0.06 in its last earnings report. Following the earnings report the stock price went up 0.787%.

Which hedge fund is a major shareholder of AFYREN?

Currently, no hedge funds are holding shares in FR:ALAFY

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

AFYREN

AFYREN SAS provides biobased products to replace petroleum-based molecules in France. The company offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids. Its products are used in the flavors and fragrances, lubricants and functional fluids, feed, food, life sciences, and materials science markets. The company was founded in 2012 and is headquartered in Clermont-Ferrand, France.